TD Cowen analyst Steve Scala maintained a Hold rating on Merck & Company (MRK – Research Report) today and set a price target of $100.00.

With the CSF-1R inhibitor space heating up, Merck KGaA has gone all-in on pimicotinib, paying Abbisko Therapeutics $85 million to secure the global license to the drug. The German pharma ...

NEW YORK, NY / ACCESS Newswire / April 2, 2025 / If you suffered a loss on your Merck & Co., Inc. (NYSE:MRK) investment and want to learn ...

Purity Sulfuric Acid Market by Grade (PPB, PPT), Application (Cleaning, Etching), End-Use Industry (Semiconductor ...

Microsoft just turned 50 and there's no better time to revisit Windows logos. Here's a brief on Windows Logo evolution.

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The company offers human health pharmaceutical for various areas ...

Big pharmaceutical stocks mostly rose after President Trump’s executive order exempted medicines from new tariffs. Merck, Bristol-Myers Squibb, and Johnson & Johnson were among the top ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

The report "High-Purity Sulfuric Acid Market by Grade (PPB, PPT), Application (Cleaning, Etching), End-Use Industry (Semiconductor & Electronics ...

The trial compared Moderna's MRNA-4157/V940 vaccine given alongside Merck & Co's cancer immunotherapy Keytruda (pembrolizumab) to Keytruda alone in patients with the skin cancer melanoma.

Merck & Co has entered into a worldwide licensing deal with Opko Health’s ModeX Therapeutics unit for a vaccine candidate against Epstein-Barr virus (EBV) that could be worth up to $922.5 ...

The global Traditional Wound Care Market , valued at US$7.15 billion in 2024, is forecasted to grow at a robust CAGR of 4.2%, reaching US$7.42 billion in 2025 and an impressive US$9.12 billion by 2030 ...